A Pan-Canadian Validation Study for the Detection of EGFR T790M Mutation Using Circulating Tumor DNA From Peripheral Blood

INTRODUCTION: Genotyping circulating tumor DNA (ctDNA) is a promising noninvasive clinical tool to identify the EGFR T790M resistance mutation in patients with advanced NSCLC with resistance to EGFR inhibitors. To facilitate standardization and clinical adoption of ctDNA testing across Canada, we de...

Descripción completa

Detalles Bibliográficos
Autores principales: Selvarajah, Shamini, Plante, Sophie, Speevak, Marsha, Vaags, Andrea, Hamelinck, Darren, Butcher, Martin, McCready, Elizabeth, Grafodatskaya, Daria, Blais, Normand, Tran-Thanh, Danh, Weng, Xiaoduan, Nassabein, Rami, Greer, Wenda, Walton, Ryan N., Lo, Bryan, Demetrick, Doug, Santos, Stephanie, Sadikovic, Bekim, Zhang, Xiao, Zhang, Tong, Spence, Tara, Stockley, Tracy, Feilotter, Harriet, Joubert, Philippe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474449/
https://www.ncbi.nlm.nih.gov/pubmed/34590051
http://dx.doi.org/10.1016/j.jtocrr.2021.100212

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8474449/
https://www.ncbi.nlm.nih.gov/pubmed/34590051
http://dx.doi.org/10.1016/j.jtocrr.2021.100212

Ejemplares similares